breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Predicted mutations | ||||||
---|---|---|---|---|---|---|
evidence | position | mutation | freq | annotation | gene | description |
RA | 53,376 | G→A | 7.9% | P14L (CCC→CTC) | pdxA ← | 4‑hydroxy‑L‑threonine phosphate dehydrogenase, NAD‑dependent |
RA | 53,379 | T→C | 7.1% | E13G (GAG→GGG) | pdxA ← | 4‑hydroxy‑L‑threonine phosphate dehydrogenase, NAD‑dependent |
RA | 72,205 | T→G | 5.4% | intergenic (+90/+24) | yabI → / ← thiQ | DedA family inner membrane protein/thiamine/thiamine pyrophosphate ABC transporter ATPase |
RA | 72,206 | C→A | 5.3% | intergenic (+91/+23) | yabI → / ← thiQ | DedA family inner membrane protein/thiamine/thiamine pyrophosphate ABC transporter ATPase |
RA | 83,587 | A→C | 9.1% | intergenic (‑58/+35) | leuA ← / ← leuL | 2‑isopropylmalate synthase/leu operon leader peptide |
RA | 83,590 | G→T | 9.4% | intergenic (‑61/+32) | leuA ← / ← leuL | 2‑isopropylmalate synthase/leu operon leader peptide |
RA | 151,519 | A→C | 10.4% | I27M (ATT→ATG) | yadK ← | putative fimbrial‑like adhesin protein |
RA | 151,522 | G→T | 9.8% | A26A (GCC→GCA) | yadK ← | putative fimbrial‑like adhesin protein |
RA | 208,552 | T→A | 6.0% | L1143I (TTA→ATA) | dnaE → | DNA polymerase III alpha subunit |
RA | 224,967 | A→C | 5.2% | noncoding (1197/1542 nt) | rrsH → | 16S ribosomal RNA of rrnH operon |
MC JC | 257,908 | Δ776 bp | 100% | [crl] | [crl] | |
RA | 285,882 | T→G | 6.1% | I163S (ATC→AGC) | yagG → | CP4‑6 prophage; putative sugar transporter |
RA | 285,887 | C→A | 5.9% | L165M (CTG→ATG) | yagG → | CP4‑6 prophage; putative sugar transporter |
RA | 314,255 | T→C | 8.4% | intergenic (‑450/‑102) | ykgP ← / → eaeH | pseudogene, oxidoreductase family/pseudogene, attaching and effacing protein homology;factor; Not classified |
RA | 314,258 | G→A | 7.6% | intergenic (‑453/‑99) | ykgP ← / → eaeH | pseudogene, oxidoreductase family/pseudogene, attaching and effacing protein homology;factor; Not classified |
RA | 374,682 | C→T | 6.5% | P272L (CCG→CTG) ‡ | mhpE → | 4‑hyroxy‑2‑oxovalerate/4‑hydroxy‑2‑oxopentanoic acid aldolase, class I |
RA | 374,683 | G→C | 6.5% | P272P (CCG→CCC) ‡ | mhpE → | 4‑hyroxy‑2‑oxovalerate/4‑hydroxy‑2‑oxopentanoic acid aldolase, class I |
RA | 374,688 | G→C | 6.4% | R274P (CGA→CCA) ‡ | mhpE → | 4‑hyroxy‑2‑oxovalerate/4‑hydroxy‑2‑oxopentanoic acid aldolase, class I |
RA | 374,689 | A→G | 7.4% | R274R (CGA→CGG) ‡ | mhpE → | 4‑hyroxy‑2‑oxovalerate/4‑hydroxy‑2‑oxopentanoic acid aldolase, class I |
RA | 464,358 | T→G | 5.1% | intergenic (+50/‑44) | ybaV → / → fadM | putative competence‑suppressing periplasmic helix‑hairpin‑helix DNA‑binding protein/long‑chain acyl‑CoA thioesterase III |
RA | 475,971 | C→G | 8.2% | intergenic (+20/+11) | ybaY → / ← ybaZ | outer membrane lipoprotein/excision repair protein, alkyltransferase‑like protein ATL |
RA | 475,972 | C→G | 7.3% | intergenic (+21/+10) | ybaY → / ← ybaZ | outer membrane lipoprotein/excision repair protein, alkyltransferase‑like protein ATL |
RA | 481,225 | T→G | 10.0% | intergenic (‑517/+29) | tomB ← / ← acrB | Hha toxicity attenuator; conjugation‑related protein/multidrug efflux system protein |
RA | 481,228 | C→A | 10.4% | intergenic (‑520/+26) | tomB ← / ← acrB | Hha toxicity attenuator; conjugation‑related protein/multidrug efflux system protein |
RA | 650,529 | G→A | 5.5% | R85R (CGC→CGT) | citD ← | citrate lyase, acyl carrier (gamma) subunit |
RA | 650,532 | T→C | 5.1% | A84A (GCA→GCG) | citD ← | citrate lyase, acyl carrier (gamma) subunit |
RA | 657,531 | T→G | 7.0% | intergenic (+30/+24) | cspE → / ← flc | constitutive cold shock family transcription antitermination protein; negative regulator of cspA transcription; RNA melting protein; ssDNA‑binding protein/fluoride efflux channel, dual topology membrane protein |
RA | 657,533 | A→T | 6.9% | intergenic (+32/+22) | cspE → / ← flc | constitutive cold shock family transcription antitermination protein; negative regulator of cspA transcription; RNA melting protein; ssDNA‑binding protein/fluoride efflux channel, dual topology membrane protein |
RA | 657,535 | C→A | 6.8% | intergenic (+34/+20) | cspE → / ← flc | constitutive cold shock family transcription antitermination protein; negative regulator of cspA transcription; RNA melting protein; ssDNA‑binding protein/fluoride efflux channel, dual topology membrane protein |
RA | 672,110 | G→A | 5.6% | T26I (ACC→ATC) | lptE ← | LPS assembly OM complex LptDE, lipoprotein component |
RA | 672,113 | T→C | 5.6% | D25G (GAT→GGT) | lptE ← | LPS assembly OM complex LptDE, lipoprotein component |
RA | 710,170 | C→T | 6.2% | intergenic (+54/+30) | chiQ → / ← fur | chitosugar‑induced verified lipoprotein/ferric iron uptake regulon transcriptional repressor; autorepressor |
RA | 710,173 | A→G | 6.6% | intergenic (+57/+27) | chiQ → / ← fur | chitosugar‑induced verified lipoprotein/ferric iron uptake regulon transcriptional repressor; autorepressor |
RA | 770,805 | G→A | 11.1% | intergenic (+194/‑653) | mngB → / → cydA | alpha‑mannosidase/cytochrome d terminal oxidase, subunit I |
RA | 770,810 | T→C | 12.5% | intergenic (+199/‑648) | mngB → / → cydA | alpha‑mannosidase/cytochrome d terminal oxidase, subunit I |
RA | 773,553 | T→C | 5.3% | L171P (CTG→CCG) ‡ | cydB → | cytochrome d terminal oxidase, subunit II |
RA | 773,554 | G→A | 5.3% | L171L (CTG→CTA) ‡ | cydB → | cytochrome d terminal oxidase, subunit II |
RA | 847,213 | A→T | 6.3% | intergenic (‑94/+45) | glnP ← / ← glnH | glutamine transporter subunit/glutamine transporter subunit |
RA | 847,214 | T→A | 6.2% | intergenic (‑95/+44) | glnP ← / ← glnH | glutamine transporter subunit/glutamine transporter subunit |
RA | 847,215 | A→T | 6.5% | intergenic (‑96/+43) | glnP ← / ← glnH | glutamine transporter subunit/glutamine transporter subunit |
RA | 857,576 | T→C | 10.4% | intergenic (+21/+220) | ybiT → / ← ybiU | ABC‑F family putative regulatory ATPase/DUF1479 family protein |
RA | 857,578 | C→G | 10.4% | intergenic (+23/+218) | ybiT → / ← ybiU | ABC‑F family putative regulatory ATPase/DUF1479 family protein |
RA | 857,580 | G→A | 10.4% | intergenic (+25/+216) | ybiT → / ← ybiU | ABC‑F family putative regulatory ATPase/DUF1479 family protein |
RA | 887,392 | T→A | 7.1% | intergenic (‑53/‑31) | ybjJ ← / → rcdA | putative drug efflux MFS transporter, inner membrane protein/transcriptional regulator of csgD and ybiJI; autoregulator |
RA | 887,393 | T→A | 7.6% | intergenic (‑54/‑30) | ybjJ ← / → rcdA | putative drug efflux MFS transporter, inner membrane protein/transcriptional regulator of csgD and ybiJI; autoregulator |
RA | 892,455 | G→C | 5.4% | V163V (GTG→GTC) | rimK → | ribosomal protein S6 modification protein |
RA | 892,457 | T→A | 5.6% | I164N (ATT→AAT) | rimK → | ribosomal protein S6 modification protein |
RA | 892,459 | G→C | 5.4% | D165H (GAC→CAC) | rimK → | ribosomal protein S6 modification protein |
RA | 958,769 | C→G | 5.1% | intergenic (+28/‑43) | serC → / → aroA | 3‑phosphoserine/phosphohydroxythreonine aminotransferase/5‑enolpyruvylshikimate‑3‑phosphate synthetase |
RA | 958,771 | A→T | 5.5% | intergenic (+30/‑41) | serC → / → aroA | 3‑phosphoserine/phosphohydroxythreonine aminotransferase/5‑enolpyruvylshikimate‑3‑phosphate synthetase |
RA | 958,773 | C→G | 5.5% | intergenic (+32/‑39) | serC → / → aroA | 3‑phosphoserine/phosphohydroxythreonine aminotransferase/5‑enolpyruvylshikimate‑3‑phosphate synthetase |
RA | 964,150 | T→A | 5.0% | intergenic (+38/‑170) | ihfB → / → ycaI | integration host factor (IHF), DNA‑binding protein, beta subunit/ComEC family inner membrane protein |
RA | 1,015,912 | T→A | 10.4% | intergenic (+30/+40) | rmf → / ← fabA | ribosome modulation factor/beta‑hydroxydecanoyl thioester dehydrase |
RA | 1,064,160 | T→C | 5.4% | L42P (CTG→CCG) ‡ | yccE → | uncharacterized protein |
RA | 1,064,161 | G→A | 5.4% | L42L (CTG→CTA) ‡ | yccE → | uncharacterized protein |
RA | 1,147,548 | T→G | 5.7% | intergenic (+8/‑73) | rpmF → / → plsX | 50S ribosomal subunit protein L32/putative phosphate acyltransferase |
RA | 1,147,549 | C→A | 5.9% | intergenic (+9/‑72) | rpmF → / → plsX | 50S ribosomal subunit protein L32/putative phosphate acyltransferase |
RA | 1,170,282 | C→G | 7.3% | W31C (TGG→TGC) | ldtC ← | L,D‑transpeptidase linking Lpp to murein |
RA | 1,174,077 | G→A | 5.2% | intergenic (‑113/+15) | mfd ← / ← ycfT | transcription‑repair coupling factor/inner membrane protein |
RA | 1,174,080 | T→C | 5.7% | intergenic (‑116/+12) | mfd ← / ← ycfT | transcription‑repair coupling factor/inner membrane protein |
RA | 1,174,501 | A→T | 5.3% | L222Q (CTG→CAG) | ycfT ← | inner membrane protein |
RA | 1,174,504 | A→T | 5.4% | L221Q (CTG→CAG) | ycfT ← | inner membrane protein |
RA | 1,224,239 | A→T | 5.3% | intergenic (+332/+40) | ycgI → / ← minE | pseudogene/cell division topological specificity factor |
RA | 1,285,190 | T→A | 6.3% | L18I (TTA→ATA) | narJ → | molybdenum‑cofactor‑assembly chaperone delta subunit of nitrate reductase 1 |
RA | 1,285,193 | T→A | 6.4% | W19R (TGG→AGG) | narJ → | molybdenum‑cofactor‑assembly chaperone delta subunit of nitrate reductase 1 |
RA | 1,344,033 | A→G | 6.2% | L105P (CTG→CCG) | yciT ← | global regulator of transcription; DeoR family |
RA | 1,344,036 | G→C | 6.3% | T104S (ACT→AGT) | yciT ← | global regulator of transcription; DeoR family |
RA | 1,344,039 | C→T | 6.2% | R103Q (CGG→CAG) | yciT ← | global regulator of transcription; DeoR family |
RA | 1,388,283 | C→T | 5.0% | intergenic (+22/+22) | tyrR → / ← tpx | aromatic amino acid biosynthesis and transport regulon transcriptional regulator; autorepressor; ATPase; phosphatase/lipid hydroperoxide peroxidase |
RA | 1,388,284 | A→T | 5.3% | intergenic (+23/+21) | tyrR → / ← tpx | aromatic amino acid biosynthesis and transport regulon transcriptional regulator; autorepressor; ATPase; phosphatase/lipid hydroperoxide peroxidase |
RA | 1,388,285 | A→G | 5.3% | intergenic (+24/+20) | tyrR → / ← tpx | aromatic amino acid biosynthesis and transport regulon transcriptional regulator; autorepressor; ATPase; phosphatase/lipid hydroperoxide peroxidase |
RA | 1,426,178 | A→T | 8.5% | intergenic (+96/‑276) | ydaY → / → tmpR | pseudogene, Rac prophage;Phage or Prophage Related/Rac prophage; pseudogene, tail protein family;Phage or Prophage Related; putative alpha helix protein |
RA | 1,449,050 | T→A | 5.0% | intergenic (+32/+26) | feaB → / ← tynA | phenylacetaldehyde dehydrogenase/tyramine oxidase, copper‑requiring |
RA | 1,498,892 | A→T | 5.2% | intergenic (+17/‑46) | ydcH → / → rimL | DUF465 family protein/ribosomal‑protein‑L7/L12‑serine acetyltransferase |
RA | 1,498,894 | C→G | 5.5% | intergenic (+19/‑44) | ydcH → / → rimL | DUF465 family protein/ribosomal‑protein‑L7/L12‑serine acetyltransferase |
RA | 1,498,896 | A→T | 5.3% | intergenic (+21/‑42) | ydcH → / → rimL | DUF465 family protein/ribosomal‑protein‑L7/L12‑serine acetyltransferase |
RA | 1,541,077 | G→C | 5.2% | A505G (GCC→GGC) | narZ ← | nitrate reductase 2 (NRZ), alpha subunit |
RA | 1,608,704 | A→G | 6.2% | S107P (TCG→CCG) | yneE ← | bestrophin family putative inner membrane protein |
RA | 1,608,707 | C→T | 7.6% | D106N (GAT→AAT) | yneE ← | bestrophin family putative inner membrane protein |
RA | 1,684,016 | A→G | 5.7% | S379G (AGC→GGC) | rstB → | sensory histidine kinase of RstAB two‑component system |
RA | 1,685,527 | A→G | 100% | G354G (GGT→GGC) | fumC ← | fumarate hydratase (fumarase C),aerobic Class II |
RA | 1,698,585 | T→G | 5.4% | E199A (GAA→GCA) | malI ← | transcriptional repressor of Mal regulon |
RA | 1,698,587 | T→A | 5.3% | A198A (GCA→GCT) ‡ | malI ← | transcriptional repressor of Mal regulon |
RA | 1,698,589 | C→A | 5.3% | A198S (GCA→TCA) ‡ | malI ← | transcriptional repressor of Mal regulon |
RA | 1,703,251 | A→T | 6.7% | intergenic (+17/+17) | add → / ← ydgJ | adenosine deaminase/putative oxidoreductase |
RA | 1,703,252 | A→T | 7.3% | intergenic (+18/+16) | add → / ← ydgJ | adenosine deaminase/putative oxidoreductase |
RA | 1,712,337 | A→T | 5.2% | intergenic (+179/‑432) | nth → / → dtpA | DNA glycosylase and apyrimidinic (AP) lyase (endonuclease III)/dipeptide and tripeptide permease A |
RA | 1,712,338 | A→T | 5.2% | intergenic (+180/‑431) | nth → / → dtpA | DNA glycosylase and apyrimidinic (AP) lyase (endonuclease III)/dipeptide and tripeptide permease A |
RA | 1,757,688 | T→A | 5.9% | intergenic (+31/+33) | lpp → / ← ldtE | murein lipoprotein/murein L,D‑transpeptidase |
RA | 1,856,334 | C→A | 5.4% | E199* (GAG→TAG) | ydjH ← | putative kinase |
RA | 1,865,682 | G→C | 6.9% | intergenic (‑46/+44) | yeaE ← / ← mipA | aldo‑keto reductase, methylglyoxal to acetol, NADPH‑dependent/scaffolding protein for murein synthesizing machinery |
MC JC | 1,978,503 | Δ776 bp | 100% | insB1–insA | insB1, insA | |
RA | 1,985,112 | C→G | 11.0% | intergenic (‑43/+27) | araG ← / ← araF | L‑arabinose ABC transporter ATPase/L‑arabinose ABC transporter periplasmic binding protein |
RA | 2,090,122 | A→G | 5.9% | intergenic (+76/‑70) | hisL → / → hisG | his operon leader peptide/ATP phosphoribosyltransferase |
RA | 2,090,124 | C→G | 5.8% | intergenic (+78/‑68) | hisL → / → hisG | his operon leader peptide/ATP phosphoribosyltransferase |
RA | 2,090,126 | C→T | 6.8% | intergenic (+80/‑66) | hisL → / → hisG | his operon leader peptide/ATP phosphoribosyltransferase |
RA | 2,145,313 | C→A | 100% | S683Y (TCC→TAC) | yegE → | putative diguanylate cyclase |
RA | 2,173,361 | Δ2 bp | 100% | pseudogene (1‑2/442 nt) | gatC ← | pseudogene, galactitol‑specific enzyme IIC component of PTS;transport; Transport of small molecules: Carbohydrates, organic acids, alcohols; PTS system galactitol‑specific enzyme IIC |
RA | 2,177,332 | C→T | 5.6% | intergenic (‑128/+180) | gatY ← / ← fbaB | D‑tagatose 1,6‑bisphosphate aldolase 2, catalytic subunit/fructose‑bisphosphate aldolase class I |
RA | 2,177,337 | G→T | 5.3% | intergenic (‑133/+175) | gatY ← / ← fbaB | D‑tagatose 1,6‑bisphosphate aldolase 2, catalytic subunit/fructose‑bisphosphate aldolase class I |
RA | 2,177,340 | A→C | 5.3% | intergenic (‑136/+172) | gatY ← / ← fbaB | D‑tagatose 1,6‑bisphosphate aldolase 2, catalytic subunit/fructose‑bisphosphate aldolase class I |
RA | 2,177,345 | A→G | 5.4% | intergenic (‑141/+167) | gatY ← / ← fbaB | D‑tagatose 1,6‑bisphosphate aldolase 2, catalytic subunit/fructose‑bisphosphate aldolase class I |
RA | 2,291,284 | C→A | 5.4% | intergenic (+137/+74) | narP → / ← ccmH | response regulator in two‑component regulatory system with NarQ/heme lyase, CcmH subunit |
RA | 2,314,800 | A→C | 5.1% | Q438P (CAG→CCG) ‡ | rcsD → | phosphotransfer intermediate protein in two‑component regulatory system with RcsBC |
RA | 2,314,801 | G→T | 5.2% | Q438H (CAG→CAT) ‡ | rcsD → | phosphotransfer intermediate protein in two‑component regulatory system with RcsBC |
RA | 2,318,095 | C→G | 100% | L594F (TTG→TTC) | rcsC ← | hybrid sensory kinase in two‑component regulatory system with RcsB and YojN |
RA | 2,326,752 | G→C | 5.3% | S215T (AGT→ACT) | atoB → | acetyl‑CoA acetyltransferase |
RA | 2,373,177 | G→A | 5.4% | G96S (GGC→AGC) | arnF → | undecaprenyl phosphate‑alpha‑L‑ara4N exporter; flippase ArnEF subunit |
RA | 2,373,180 | T→C | 5.5% | W97R (TGG→CGG) | arnF → | undecaprenyl phosphate‑alpha‑L‑ara4N exporter; flippase ArnEF subunit |
RA | 2,383,956 | A→T | 16.5% | intergenic (+32/+39) | elaD → / ← yfbK | protease, capable of cleaving an AMC‑ubiquitin model substrate/Von Willebrand factor domain putative lipoprotein |
RA | 2,383,959 | A→T | 16.5% | intergenic (+35/+36) | elaD → / ← yfbK | protease, capable of cleaving an AMC‑ubiquitin model substrate/Von Willebrand factor domain putative lipoprotein |
RA | 2,432,985 | A→G | 8.0% | intergenic (‑43/+27) | folC ← / ← accD | bifunctional folylpolyglutamate synthase/ dihydrofolate synthase/acetyl‑CoA carboxylase, beta (carboxyltransferase) subunit |
RA | 2,432,990 | G→C | 7.7% | intergenic (‑48/+22) | folC ← / ← accD | bifunctional folylpolyglutamate synthase/ dihydrofolate synthase/acetyl‑CoA carboxylase, beta (carboxyltransferase) subunit |
RA | 2,432,995 | C→T | 7.0% | intergenic (‑53/+17) | folC ← / ← accD | bifunctional folylpolyglutamate synthase/ dihydrofolate synthase/acetyl‑CoA carboxylase, beta (carboxyltransferase) subunit |
RA | 2,521,344 | C→T | 8.1% | intergenic (+16/+249) | lysV → / ← xapR | tRNA‑Lys/transcriptional activator of xapAB |
RA | 2,521,346 | A→T | 7.8% | intergenic (+18/+247) | lysV → / ← xapR | tRNA‑Lys/transcriptional activator of xapAB |
RA | 2,521,348 | A→G | 7.7% | intergenic (+20/+245) | lysV → / ← xapR | tRNA‑Lys/transcriptional activator of xapAB |
RA | 2,521,502 | A→T | 5.1% | intergenic (+174/+91) | lysV → / ← xapR | tRNA‑Lys/transcriptional activator of xapAB |
RA | 2,521,504 | A→G | 5.9% | intergenic (+176/+89) | lysV → / ← xapR | tRNA‑Lys/transcriptional activator of xapAB |
RA | 2,566,266 | C→A | 5.3% | G207C (GGC→TGC) | eutA ← | reactivating factor for ethanolamine ammonia lyase |
RA | 2,596,873 | Δ1 bp | 5.7% | intergenic (‑136/+32) | ypfJ ← / ← purC | putative neutral zinc metallopeptidase/phosphoribosylaminoimidazole‑succinocarboxamide synthetase |
RA | 2,596,878:1 | +G | 5.7% | intergenic (‑141/+27) | ypfJ ← / ← purC | putative neutral zinc metallopeptidase/phosphoribosylaminoimidazole‑succinocarboxamide synthetase |
RA | 2,652,133 | A→C | 5.1% | V52G (GTG→GGG) | yfhM ← | bacterial alpha2‑macroglobulin colonization factor ECAM; anti‑host protease defense factor; periplasmic inner membrane‑anchored lipoprotein |
RA | 2,704,304 | A→G | 7.6% | intergenic (‑241/+31) | rnc ← / ← lepB | RNase III/leader peptidase (signal peptidase I) |
RA | 2,704,306 | A→T | 8.2% | intergenic (‑243/+29) | rnc ← / ← lepB | RNase III/leader peptidase (signal peptidase I) |
RA | 2,704,308 | C→T | 7.7% | intergenic (‑245/+27) | rnc ← / ← lepB | RNase III/leader peptidase (signal peptidase I) |
RA | 2,706,121:1 | +T | 6.4% | coding (1004/1800 nt) | lepA ← | back‑translocating elongation factor EF4, GTPase |
RA | 2,706,606 | G→T | 6.0% | L173L (CTC→CTA) ‡ | lepA ← | back‑translocating elongation factor EF4, GTPase |
RA | 2,706,607 | A→C | 6.1% | L173R (CTC→CGC) ‡ | lepA ← | back‑translocating elongation factor EF4, GTPase |
RA | 2,707,320 | A→T | 6.4% | intergenic (‑196/+2) | lepA ← / ← rseC | back‑translocating elongation factor EF4, GTPase/SoxR iron‑sulfur cluster reduction factor component |
RA | 2,707,321 | A→T | 6.4% | intergenic (‑197/+1) | lepA ← / ← rseC | back‑translocating elongation factor EF4, GTPase/SoxR iron‑sulfur cluster reduction factor component |
RA | 2,716,030 | T→G | 5.5% | intergenic (+20/+36) | eamB → / ← grcA | cysteine and O‑acetylserine exporter/autonomous glycyl radical cofactor |
RA | 2,724,095 | C→A | 6.1% | intergenic (+13/‑33) | pssA → / → yfiM | phosphatidylserine synthase; CDP‑diacylglycerol‑serine O‑phosphatidyltransferase/putative lipoprotein |
RA | 2,724,097 | T→A | 5.5% | intergenic (+15/‑31) | pssA → / → yfiM | phosphatidylserine synthase; CDP‑diacylglycerol‑serine O‑phosphatidyltransferase/putative lipoprotein |
RA | 2,724,099 | T→G | 6.1% | intergenic (+17/‑29) | pssA → / → yfiM | phosphatidylserine synthase; CDP‑diacylglycerol‑serine O‑phosphatidyltransferase/putative lipoprotein |
RA | 2,750,086 | A→C | 5.1% | intergenic (+26/+29) | yfjD → / ← grpE | UPF0053 family inner membrane protein/heat shock protein |
RA | 2,753,986 | A→T | 5.1% | intergenic (+40/+22) | bamE → / ← ratB | lipoprotein component of BamABCDE OM biogenesis complex/UPF0125 family protein |
RA | 2,761,620 | T→G | 6.7% | K641Q (AAG→CAG) | yfjK ← | radiation resistance protein; DEAD/H helicase‑like protein; CP4‑57 putative defective prophage |
RA | 2,761,623 | C→A | 6.6% | V640L (GTA→TTA) | yfjK ← | radiation resistance protein; DEAD/H helicase‑like protein; CP4‑57 putative defective prophage |
RA | 2,800,515 | C→A | 5.6% | intergenic (+40/‑208) | ygaM → / → nrdH | putative membrane‑anchored DUF883 family ribosome‑binding protein/hydrogen donor for NrdEF electron transport system; glutaredoxin‑like protein |
RA | 2,800,517 | T→A | 6.0% | intergenic (+42/‑206) | ygaM → / → nrdH | putative membrane‑anchored DUF883 family ribosome‑binding protein/hydrogen donor for NrdEF electron transport system; glutaredoxin‑like protein |
RA | 2,800,519 | T→G | 5.6% | intergenic (+44/‑204) | ygaM → / → nrdH | putative membrane‑anchored DUF883 family ribosome‑binding protein/hydrogen donor for NrdEF electron transport system; glutaredoxin‑like protein |
RA | 2,801,056 | A→T | 5.9% | N31I (AAT→ATT) | nrdI → | NrdEF cluster assembly flavodoxin |
RA | 2,810,872 | C→T | 8.1% | H35Y (CAC→TAC) ‡ | mprA → | transcriptional repressor of microcin B17 synthesis and multidrug efflux |
RA | 2,810,873 | A→G | 8.3% | H35R (CAC→CGC) ‡ | mprA → | transcriptional repressor of microcin B17 synthesis and multidrug efflux |
RA | 2,814,174 | T→A | 8.3% | intergenic (+20/+44) | emrB → / ← luxS | multidrug efflux system protein/S‑ribosylhomocysteine lyase |
RA | 2,814,175 | T→A | 8.3% | intergenic (+21/+43) | emrB → / ← luxS | multidrug efflux system protein/S‑ribosylhomocysteine lyase |
RA | 2,814,860 | A→G | 7.9% | noncoding (59/78 nt) | micA → | sRNA antisense regulator of ompA, lamB, ompX, and phoP; Hfq‑dependent |
RA | 2,814,861 | C→T | 8.2% | noncoding (60/78 nt) | micA → | sRNA antisense regulator of ompA, lamB, ompX, and phoP; Hfq‑dependent |
RA | 2,860,736 | C→G | 5.7% | D167H (GAT→CAT) | ygbI ← | DeoR family putative transcriptional regulator |
RA | 2,860,738 | A→T | 5.8% | I166N (ATT→AAT) | ygbI ← | DeoR family putative transcriptional regulator |
RA | 2,860,740 | C→G | 6.0% | M165I (ATG→ATC) | ygbI ← | DeoR family putative transcriptional regulator |
RA | 2,866,487 | G→C | 8.0% | intergenic (+22/+72) | ygbN → / ← rpoS | putative transporter/RNA polymerase, sigma S (sigma 38) factor |
RA | 2,866,488 | G→C | 8.0% | intergenic (+23/+71) | ygbN → / ← rpoS | putative transporter/RNA polymerase, sigma S (sigma 38) factor |
RA | 2,907,998 | A→T | 6.0% | intergenic (‑57/+31) | eno ← / ← pyrG | enolase/CTP synthetase |
RA | 2,951,471 | G→A | 6.2% | R331C (CGC→TGC) | recD ← | exonuclease V (RecBCD complex), alpha chain |
RA | 2,951,475 | T→A | 6.1% | L329L (CTA→CTT) | recD ← | exonuclease V (RecBCD complex), alpha chain |
RA | 3,092,774:1 | +A | 6.7% | coding (897/951 nt) | gshB → | glutathione synthetase |
RA | 3,092,779 | Δ1 bp | 6.4% | coding (902/951 nt) | gshB → | glutathione synthetase |
RA | 3,101,541 | G→C | 9.7% | P28R (CCG→CGG) | yggN ← | DUF2884 family putative periplasmic protein |
RA | 3,140,351 | C→T | 5.7% | R150H (CGC→CAC) ‡ | hybE ← | hydrogenase 2‑specific chaperone |
RA | 3,140,352 | G→C | 5.7% | R150G (CGC→GGC) ‡ | hybE ← | hydrogenase 2‑specific chaperone |
RA | 3,140,353 | A→G | 5.6% | R149R (CGT→CGC) | hybE ← | hydrogenase 2‑specific chaperone |
RA | 3,156,590 | C→A | 9.5% | intergenic (+72/‑33) | yqhD → / → dkgA | aldehyde reductase, NADPH‑dependent/2,5‑diketo‑D‑gluconate reductase A |
RA | 3,156,591 | T→G | 9.6% | intergenic (+73/‑32) | yqhD → / → dkgA | aldehyde reductase, NADPH‑dependent/2,5‑diketo‑D‑gluconate reductase A |
RA | 3,171,863 | A→G | 6.5% | intergenic (+30/+16) | qseC → / ← ygiZ | quorum sensing sensory histidine kinase in two‑component regulatory system with QseB/inner membrane protein |
RA | 3,180,505 | G→T | 7.2% | E29* (GAG→TAG) ‡ | ygiC → | ATP‑Grasp family ATPase |
RA | 3,180,506 | A→C | 7.2% | E29A (GAG→GCG) ‡ | ygiC → | ATP‑Grasp family ATPase |
RA | 3,206,172 | T→C | 5.9% | T29A (ACG→GCG) | ttdR ← | transcriptional activator of ttdABT |
RA | 3,206,176 | C→A | 6.0% | A27A (GCG→GCT) | ttdR ← | transcriptional activator of ttdABT |
RA | 3,206,179 | T→G | 6.8% | A26A (GCA→GCC) | ttdR ← | transcriptional activator of ttdABT |
RA | 3,206,183 | G→A | 6.1% | A25V (GCC→GTC) | ttdR ← | transcriptional activator of ttdABT |
RA | 3,208,201 | G→A | 5.9% | V60M (GTG→ATG) | ttdT → | L‑tartrate/succinate antiporte |
RA | 3,208,205 | G→A | 5.6% | G61D (GGT→GAT) | ttdT → | L‑tartrate/succinate antiporte |
RA | 3,208,210 | T→C | 5.8% | S63P (TCC→CCC) | ttdT → | L‑tartrate/succinate antiporte |
RA | 3,288,032 | C→A | 6.7% | intergenic (+22/‑58) | yraH → / → yraI | putative fimbrial‑like adhesin protein/putative periplasmic pilin chaperone |
RA | 3,288,033 | T→G | 6.6% | intergenic (+23/‑57) | yraH → / → yraI | putative fimbrial‑like adhesin protein/putative periplasmic pilin chaperone |
RA | 3,313,207 | G→A | 5.4% | intergenic (‑29/+135) | rbfA ← / ← infB | 30s ribosome binding factor/translation initiation factor IF‑2 |
RA | 3,313,208 | T→A | 5.4% | intergenic (‑30/+134) | rbfA ← / ← infB | 30s ribosome binding factor/translation initiation factor IF‑2 |
RA | 3,313,209 | T→C | 5.4% | intergenic (‑31/+133) | rbfA ← / ← infB | 30s ribosome binding factor/translation initiation factor IF‑2 |
RA | 3,334,703 | A→G | 5.5% | intergenic (+22/‑206) | ispB → / → sfsB | octaprenyl diphosphate synthase/malPQ operon transcriptional activator |
RA | 3,334,704 | G→C | 5.6% | intergenic (+23/‑205) | ispB → / → sfsB | octaprenyl diphosphate synthase/malPQ operon transcriptional activator |
RA | 3,334,705 | C→T | 5.7% | intergenic (+24/‑204) | ispB → / → sfsB | octaprenyl diphosphate synthase/malPQ operon transcriptional activator |
RA | 3,407,293 | T→A | 5.0% | intergenic (+27/‑82) | accC → / → yhdT | acetyl‑CoA carboxylase, biotin carboxylase subunit/DUF997 family putative inner membrane protein |
RA | 3,407,294 | T→A | 5.0% | intergenic (+28/‑81) | accC → / → yhdT | acetyl‑CoA carboxylase, biotin carboxylase subunit/DUF997 family putative inner membrane protein |
RA | 3,407,295 | T→A | 5.0% | intergenic (+29/‑80) | accC → / → yhdT | acetyl‑CoA carboxylase, biotin carboxylase subunit/DUF997 family putative inner membrane protein |
RA | 3,439,588 | G→C | 6.2% | intergenic (‑79/+28) | yhdN ← / ← rplQ | DUF1992 family protein/50S ribosomal subunit protein L17 |
RA | 3,439,589 | G→C | 5.9% | intergenic (‑80/+27) | yhdN ← / ← rplQ | DUF1992 family protein/50S ribosomal subunit protein L17 |
RA | 3,477,878 | T→A | 5.2% | intergenic (+20/+29) | slyX → / ← slyD | phi X174 lysis protein/FKBP‑type peptidyl prolyl cis‑trans isomerase (rotamase) |
RA | 3,560,455:1 | +G | 100% | intergenic (‑2/+1) | glpR ← / ← glpR | pseudogene, DNA‑binding transcriptional repressor;regulator; Energy metabolism, carbon: Anaerobic respiration; repressor of the glp operon/pseudogene, DNA‑binding transcriptional repressor;regulator; Energy metabolism, carbon: Anaerobic respiration; repressor of the glp operon |
RA | 3,587,225 | A→T | 5.4% | M95L (ATG→TTG) | yhhA → | DUF2756 family protein |
RA | 3,608,689 | G→T | 5.3% | intergenic (+40/+62) | zntA → / ← tusA | zinc, cobalt and lead efflux system/mnm(5)‑s(2)U34‑tRNA 2‑thiolation sulfurtransferase |
RA | 3,608,694 | T→A | 5.8% | intergenic (+45/+57) | zntA → / ← tusA | zinc, cobalt and lead efflux system/mnm(5)‑s(2)U34‑tRNA 2‑thiolation sulfurtransferase |
RA | 3,608,695 | C→G | 7.3% | intergenic (+46/+56) | zntA → / ← tusA | zinc, cobalt and lead efflux system/mnm(5)‑s(2)U34‑tRNA 2‑thiolation sulfurtransferase |
RA | 3,608,701 | A→C | 7.4% | intergenic (+52/+50) | zntA → / ← tusA | zinc, cobalt and lead efflux system/mnm(5)‑s(2)U34‑tRNA 2‑thiolation sulfurtransferase |
RA | 3,657,599 | T→A | 6.6% | intergenic (+32/+387) | hdeD → / ← arrS | acid‑resistance membrane protein/antisense sRNA ArrS, function unknown |
RA | 3,657,601 | G→C | 6.6% | intergenic (+34/+385) | hdeD → / ← arrS | acid‑resistance membrane protein/antisense sRNA ArrS, function unknown |
RA | 3,657,603 | T→A | 6.7% | intergenic (+36/+383) | hdeD → / ← arrS | acid‑resistance membrane protein/antisense sRNA ArrS, function unknown |
RA | 3,720,294 | T→C | 9.9% | intergenic (+33/+154) | cspA → / ← hokA | RNA chaperone and antiterminator, cold‑inducible/toxic polypeptide, small |
RA | 3,720,299 | T→A | 9.8% | intergenic (+38/+149) | cspA → / ← hokA | RNA chaperone and antiterminator, cold‑inducible/toxic polypeptide, small |
RA | 3,720,300 | T→A | 9.4% | intergenic (+39/+148) | cspA → / ← hokA | RNA chaperone and antiterminator, cold‑inducible/toxic polypeptide, small |
RA | 3,720,305 | G→A | 8.5% | intergenic (+44/+143) | cspA → / ← hokA | RNA chaperone and antiterminator, cold‑inducible/toxic polypeptide, small |
RA | 3,774,207 | C→T | 6.6% | intergenic (+13/‑217) | mtlA → / → mtlD | mannitol‑specific PTS enzyme: IIA, IIB and IIC components/mannitol‑1‑phosphate dehydrogenase, NAD‑dependent |
RA | 3,774,214 | C→T | 6.7% | intergenic (+20/‑210) | mtlA → / → mtlD | mannitol‑specific PTS enzyme: IIA, IIB and IIC components/mannitol‑1‑phosphate dehydrogenase, NAD‑dependent |
RA | 3,774,215 | A→G | 7.0% | intergenic (+21/‑209) | mtlA → / → mtlD | mannitol‑specific PTS enzyme: IIA, IIB and IIC components/mannitol‑1‑phosphate dehydrogenase, NAD‑dependent |
RA | 3,774,222 | A→G | 5.7% | intergenic (+28/‑202) | mtlA → / → mtlD | mannitol‑specific PTS enzyme: IIA, IIB and IIC components/mannitol‑1‑phosphate dehydrogenase, NAD‑dependent |
RA | 3,781,051 | C→G | 10.7% | intergenic (+34/‑164) | lldD → / → trmL | L‑lactate dehydrogenase, FMN‑linked/tRNA Leu mC34,mU34 2'‑O‑methyltransferase, SAM‑dependent |
RA | 3,790,300 | A→T | 6.0% | intergenic (‑219/+20) | waaH ← / ← tdh | LPS(HepIII)‑glucuronic acid glycosyltransferase/L‑threonine 3‑dehydrogenase, NAD(P)‑binding |
RA | 3,790,303 | A→T | 5.8% | intergenic (‑222/+17) | waaH ← / ← tdh | LPS(HepIII)‑glucuronic acid glycosyltransferase/L‑threonine 3‑dehydrogenase, NAD(P)‑binding |
RA | 3,798,234 | A→T | 5.4% | intergenic (+27/+5) | waaL → / ← waaU | O‑antigen ligase/lipopolysaccharide core biosynthesis |
RA | 3,798,235 | A→T | 5.4% | intergenic (+28/+4) | waaL → / ← waaU | O‑antigen ligase/lipopolysaccharide core biosynthesis |
RA | 3,877,558 | G→C | 9.2% | intergenic (‑93/+147) | yidB ← / ← gyrB | DUF937 family protein/DNA gyrase, subunit B |
RA | 3,888,212 | Δ1 bp | 7.6% | intergenic (+20/‑223) | mnmE → / → tnaC | tRNA U34 5‑methylaminomethyl‑2‑thiouridine modification GTPase/tryptophanase leader peptide |
RA | 3,888,219 | T→A | 10.1% | intergenic (+27/‑216) | mnmE → / → tnaC | tRNA U34 5‑methylaminomethyl‑2‑thiouridine modification GTPase/tryptophanase leader peptide |
RA | 3,888,224:1 | +A | 9.5% | intergenic (+32/‑211) | mnmE → / → tnaC | tRNA U34 5‑methylaminomethyl‑2‑thiouridine modification GTPase/tryptophanase leader peptide |
RA | 3,891,502 | C→G | 8.8% | intergenic (+19/‑113) | tnaB → / → mdtL | tryptophan transporter of low affinity/multidrug efflux system protein |
RA | 3,891,504 | T→A | 8.9% | intergenic (+21/‑111) | tnaB → / → mdtL | tryptophan transporter of low affinity/multidrug efflux system protein |
RA | 3,891,506 | C→G | 8.5% | intergenic (+23/‑109) | tnaB → / → mdtL | tryptophan transporter of low affinity/multidrug efflux system protein |
RA | 3,959,515 | T→A | 7.8% | intergenic (+70/+17) | ilvC → / ← ppiC | ketol‑acid reductoisomerase, NAD(P)‑binding/peptidyl‑prolyl cis‑trans isomerase C (rotamase C) |
RA | 3,991,334 | T→A | 5.5% | I61N (ATT→AAT) ‡ | cyaA → | adenylate cyclase |
RA | 3,991,335 | T→A | 5.5% | I61I (ATT→ATA) ‡ | cyaA → | adenylate cyclase |
JC | 3,993,564 | Δ9 bp | 100% | coding (2412‑2420/2547 nt) | cyaA → | adenylate cyclase |
RA | 4,022,007 | C→T | 5.7% | G21G (GGC→GGT) | tatA → | TatABCE protein translocation system subunit |
RA | 4,022,008 | A→G | 5.9% | T22A (ACC→GCC) | tatA → | TatABCE protein translocation system subunit |
RA | 4,060,261 | G→T | 8.2% | intergenic (+31/‑186) | typA → / → yihL | GTP‑binding protein/putative DNA‑binding transcriptional regulator |
RA | 4,060,264 | A→C | 8.2% | intergenic (+34/‑183) | typA → / → yihL | GTP‑binding protein/putative DNA‑binding transcriptional regulator |
RA | 4,088,091 | G→C | 7.3% | intergenic (+34/+16) | yiiG → / ← frvR | DUF3829 family lipoprotein/putative frv operon regulator; contains a PTS EIIA domain |
RA | 4,093,463 | A→G | 5.2% | S270S (AGT→AGC) | rhaD ← | rhamnulose‑1‑phosphate aldolase |
RA | 4,130,005 | G→A | 5.8% | L57L (TTG→TTA) | metL → | Bifunctional aspartokinase/homoserine dehydrogenase 2 |
RA | 4,130,008 | T→C | 5.9% | I58I (ATT→ATC) | metL → | Bifunctional aspartokinase/homoserine dehydrogenase 2 |
RA | 4,148,049 | C→G | 5.3% | G90A (GGC→GCC) | yijO ← | AraC family putative transcriptional activator |
RA | 4,262,250 | G→C | 5.4% | G194G (GGG→GGC) | dusA → | tRNA‑dihydrouridine synthase A |
RA | 4,262,255 | G→C | 5.3% | S196T (AGC→ACC) | dusA → | tRNA‑dihydrouridine synthase A |
RA | 4,270,142 | G→A | 5.4% | intergenic (+15/‑96) | aphA → / → yjbQ | acid phosphatase/phosphotransferase, class B, non‑specific/thiamine phosphate synthase |
RA | 4,270,144 | G→C | 5.5% | intergenic (+17/‑94) | aphA → / → yjbQ | acid phosphatase/phosphotransferase, class B, non‑specific/thiamine phosphate synthase |
RA | 4,270,146 | T→C | 5.4% | intergenic (+19/‑92) | aphA → / → yjbQ | acid phosphatase/phosphotransferase, class B, non‑specific/thiamine phosphate synthase |
RA | 4,274,740 | G→A | 5.5% | intergenic (+79/+20) | ssb → / ← yjcB | single‑stranded DNA‑binding protein/putative inner membrane protein |
RA | 4,274,742 | T→A | 5.8% | intergenic (+81/+18) | ssb → / ← yjcB | single‑stranded DNA‑binding protein/putative inner membrane protein |
RA | 4,274,744 | T→C | 6.0% | intergenic (+83/+16) | ssb → / ← yjcB | single‑stranded DNA‑binding protein/putative inner membrane protein |
RA | 4,291,512 | G→A | 6.4% | M1M (GTG→ATG) †‡ | nrfE → | heme lyase (NrfEFG) for insertion of heme into c552, subunit NrfE |
RA | 4,291,513 | T→C | 6.4% | M1A (GTG→GCG) †‡ | nrfE → | heme lyase (NrfEFG) for insertion of heme into c552, subunit NrfE |
RA | 4,296,060 | C→T | 25.5% | intergenic (+266/+376) | gltP → / ← yjcO | glutamate/aspartate:proton symporter/Sel1 family TPR‑like repeat protein |
RA | 4,296,380:1 | +CG | 100% | intergenic (+586/+56) | gltP → / ← yjcO | glutamate/aspartate:proton symporter/Sel1 family TPR‑like repeat protein |
RA | 4,307,294 | A→T | 6.1% | L169Q (CTG→CAG) | alsK ← | D‑allose kinase |
RA | 4,307,298 | G→A | 6.4% | P168S (CCC→TCC) | alsK ← | D‑allose kinase |
RA | 4,314,233 | A→T | 6.0% | intergenic (+36/+111) | yjdP → / ← phnP | putative periplasmic protein/5‑phospho‑alpha‑D‑ribosyl 1,2‑cyclic phosphate phosphodiesterase |
RA | 4,335,655 | T→A | 5.1% | intergenic (‑65/+39) | eptA ← / ← adiC | lipid A phosphoethanolamine transferase/arginine:agmatine antiporter |
RA | 4,362,528 | G→A | 5.2% | intergenic (‑175/+23) | yjdQ ← / ← pheU | pseudogene, P4‑like integrase remnant/tRNA‑Phe |
RA | 4,362,529 | T→C | 5.1% | intergenic (‑176/+22) | yjdQ ← / ← pheU | pseudogene, P4‑like integrase remnant/tRNA‑Phe |
RA | 4,376,291 | T→C | 5.1% | intergenic (+26/‑26) | efp → / → ecnA | polyproline‑specific translation elongation factor EF‑P/entericidin A membrane lipoprotein, antidote entericidin B |
RA | 4,377,791 | A→T | 6.2% | intergenic (‑69/+20) | blc ← / ← ampC | outer membrane lipoprotein cell division and growth lipocalin/penicillin‑binding protein; beta‑lactamase, intrinsically weak |
RA | 4,377,792 | A→T | 6.3% | intergenic (‑70/+19) | blc ← / ← ampC | outer membrane lipoprotein cell division and growth lipocalin/penicillin‑binding protein; beta‑lactamase, intrinsically weak |
RA | 4,470,951 | A→C | 6.7% | intergenic (‑38/+35) | ridA ← / ← pyrI | enamine/imine deaminase, reaction intermediate detoxification/aspartate carbamoyltransferase, regulatory subunit |
RA | 4,470,952 | T→C | 7.1% | intergenic (‑39/+34) | ridA ← / ← pyrI | enamine/imine deaminase, reaction intermediate detoxification/aspartate carbamoyltransferase, regulatory subunit |
RA | 4,470,957 | G→A | 6.4% | intergenic (‑44/+29) | ridA ← / ← pyrI | enamine/imine deaminase, reaction intermediate detoxification/aspartate carbamoyltransferase, regulatory subunit |
RA | 4,470,958 | G→T | 6.6% | intergenic (‑45/+28) | ridA ← / ← pyrI | enamine/imine deaminase, reaction intermediate detoxification/aspartate carbamoyltransferase, regulatory subunit |
RA | 4,472,434 | G→A | 6.6% | R34* (CGA→TGA) | pyrL ← | pyrBI operon leader peptide |
RA | 4,472,437 | T→C | 6.9% | N33D (AAT→GAT) | pyrL ← | pyrBI operon leader peptide |
RA | 4,479,012 | A→T | 5.3% | intergenic (+123/+22) | rraB → / ← yjgM | protein inhibitor of RNase E/GNAT family putative N‑acetyltransferase |
RA | 4,479,016 | G→C | 5.3% | intergenic (+127/+18) | rraB → / ← yjgM | protein inhibitor of RNase E/GNAT family putative N‑acetyltransferase |
RA | 4,479,020 | A→T | 5.3% | intergenic (+131/+14) | rraB → / ← yjgM | protein inhibitor of RNase E/GNAT family putative N‑acetyltransferase |
RA | 4,498,222 | A→T | 6.1% | intergenic (+282/‑50) | intB → / → insC1 | pseudogene, integrase homology;IS, phage, Tn; Phage‑related functions and prophages; KpLE2 phage‑like element; P4‑like integrase/IS2 repressor TnpA |
RA | 4,498,223 | A→T | 6.0% | intergenic (+283/‑49) | intB → / → insC1 | pseudogene, integrase homology;IS, phage, Tn; Phage‑related functions and prophages; KpLE2 phage‑like element; P4‑like integrase/IS2 repressor TnpA |
RA | 4,512,350:1 | +G | 5.8% | coding (65/957 nt) | fecD ← | ferric citrate ABC transporter permease |
RA | 4,520,500 | Δ1 bp | 10.8% | intergenic (‑176/+171) | yjhU ← / ← yjhF | putative DNA‑binding transcriptional regulator; KpLE2 phage‑like element/putative transporter |
RA | 4,520,504:1 | +T | 10.6% | intergenic (‑180/+167) | yjhU ← / ← yjhF | putative DNA‑binding transcriptional regulator; KpLE2 phage‑like element/putative transporter |
RA | 4,549,932 | T→A | 9.0% | intergenic (+222/+21) | fimH → / ← gntP | minor component of type 1 fimbriae/fructuronate transporter |
RA | 4,638,690 | C→T | 5.2% | G171G (GGC→GGT) | creD → | inner membrane protein |
RA | 4,638,691 | A→G | 5.2% | T172A (ACC→GCC) | creD → | inner membrane protein |
Unassigned new junction evidence | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
* | ? | NC_000913 | 274384 = | NA (NA) | 3 (0.020) | 3/296 | NT | NA | noncoding (766/1195 nt) | IS5 | repeat region |
? | NC_000913 | 274422 = | NA (NA) | noncoding (728/1195 nt) | IS5 | repeat region | |||||
* | ? | NC_000913 | 274620 = | NA (NA) | 4 (0.020) | 4/284 | NT | NA | noncoding (530/1195 nt) | IS5 | repeat region |
? | NC_000913 | 274663 = | NA (NA) | noncoding (487/1195 nt) | IS5 | repeat region | |||||
* | ? | NC_000913 | 412077 = | 131 (0.770) | 7 (0.040) | 7/286 | NT | 5.3% | coding (405/1185 nt) | araJ | L‑arabinose‑inducible putative transporter, MFS family |
? | NC_000913 | 412119 = | 126 (0.780) | coding (363/1185 nt) | araJ | L‑arabinose‑inducible putative transporter, MFS family | |||||
* | ? | NC_000913 | 580753 = | 111 (0.650) | 5 (0.030) | 5/270 | NT | 5.1% | intergenic (‑308/‑81) | ylcI/nohD | DUF3950 family protein, DLP12 prophage/DLP12 prophage; DNA packaging protein |
? | NC_000913 | 580810 = | 88 (0.580) | intergenic (‑365/‑24) | ylcI/nohD | DUF3950 family protein, DLP12 prophage/DLP12 prophage; DNA packaging protein | |||||
* | ? | NC_000913 | 1207790 = | 94 (0.550) | 67 (0.440) | 54/270 | NT | 46.5% | coding (290/630 nt) | stfP | e14 prophage; uncharacterized protein |
? | NC_000913 | 1209619 = | 70 (0.460) | pseudogene (1/501 nt) | stfE | pseudogene, e14 prophage; side tail fiber protein fragment family;Phage or Prophage Related | |||||
* | ? | NC_000913 | = 1207805 | 95 (0.560) | 60 (0.390) | 48/270 | NT | 43.6% | coding (305/630 nt) | stfP | e14 prophage; uncharacterized protein |
? | NC_000913 | = 1209602 | 70 (0.460) | pseudogene (18/501 nt) | stfE | pseudogene, e14 prophage; side tail fiber protein fragment family;Phage or Prophage Related | |||||
* | ? | NC_000913 | = 1299498 | 0 (0.000) | 120 (0.720) | 88/294 | NT | 100% | intergenic (+253/‑1684) | ychE/oppA | UPF0056 family inner membrane protein/oligopeptide ABC transporter periplasmic binding protein |
? | NC_000913 | 1300698 = | 0 (0.000) | intergenic (+1453/‑484) | ychE/oppA | UPF0056 family inner membrane protein/oligopeptide ABC transporter periplasmic binding protein | |||||
* | ? | NC_000913 | = 2066832 | 62 (0.360) | 5 (0.030) | 4/284 | NT | 7.9% | noncoding (522/1195 nt) | IS5 | repeat region |
? | NC_000913 | = 2102447 | NA (NA) | noncoding (497/1195 nt) | IS5 | repeat region | |||||
* | ? | NC_000913 | 2729475 = | 126 (0.740) | 7 (0.040) | 4/282 | NT | 6.3% | intergenic (‑31/+141) | gltW/rrsG | tRNA‑Glu/16S ribosomal RNA of rrnG operon |
? | NC_000913 | = 4168363 | 90 (0.570) | intergenic (+163/‑9) | rrsB/gltT | 16S ribosomal RNA of rrnB operon/tRNA‑Glu | |||||
* | ? | NC_000913 | 3620227 = | NA (NA) | 3 (0.020) | 3/290 | NT | 100% | coding (1036/4236 nt) | rhsB | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
? | NC_000913 | 3620250 = | 0 (0.000) | coding (1059/4236 nt) | rhsB | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor | |||||
* | ? | NC_000913 | = 3620350 | NA (NA) | 4 (0.020) | 4/290 | NT | 100% | coding (1159/4236 nt) | rhsB | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
? | NC_000913 | = 3620425 | 0 (0.000) | coding (1234/4236 nt) | rhsB | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor | |||||
* | ? | NC_000913 | = 3621553 | NA (NA) | 4 (0.020) | 4/288 | NT | 100% | coding (2362/4236 nt) | rhsB | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
? | NC_000913 | = 3621603 | 0 (0.000) | coding (2412/4236 nt) | rhsB | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor | |||||
* | ? | NC_000913 | 3621989 = | NA (NA) | 5 (0.030) | 3/286 | NT | 100% | coding (2798/4236 nt) | rhsB | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
? | NC_000913 | 3622012 = | 0 (0.000) | coding (2821/4236 nt) | rhsB | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor | |||||
* | ? | NC_000913 | 3721045 = | 207 (1.220) | 428 (2.530) | 213/300 | NT | 69.6% | noncoding (413/1443 nt) | IS150 | repeat region |
? | NC_000913 | = 3839774 | 169 (1.000) | coding (220/819 nt) | nlpA | cytoplasmic membrane lipoprotein‑28 |